IP Library › Granted Patent US 8,900,596
Granted Patent B2
US 8,900,596 · App. 13/510,684 · Granted Dec 2, 2014

Physicochemical (PCP) based consensus sequences and uses thereof

Inventors: Catherine H. Schein (Friendswood, TX); Petr Danecek (Prague, CZ)
Assignee: The Board of Regents of the University of Texas System
C07K14/1825G06F19/22G01N2469/20G01N33/56983G06F19/16C07K16/1081C12N2770/24122G01N2333/185C07K2317/33C07K14/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,900,596
App. No.
13/510,684
Granted
Dec 2, 2014
Kind
B2
Abstract

Provided herein is a computational method for designing a PCP-consensus protein for a family of related proteins. The method uses a consensus alignment of a protein domain common to all the related proteins, which may or may not be substantially biased, from which an average value of p, e.g., 5, physicochemical properties are calculated for each amino acid in the alignment. The PCP-consensus protein has a sequence derived from an alignment of protein domains from a family of related proteins, said sequence containing one or more motifs common to all of the proteins. Also provided are the PCP-consensus proteins, kits comprising the same, datasets of aligned consensus sequences used to derive the PCP-consensus proteins and methods of eliciting an immune response, diagnosing or treating an infectious disease using the same.

Claims (9)

1. A physicochemical properties (PCP)-consensus protein, comprising:

an isolated polypeptide having the sequence of SEQ ID NO:329, SEQ ID NO:326, SEQ ID NO:327, or SEQ ID NO:328.

2. A physicochemical properties (PCP)-consensus protein comprising isolated polypeptide having the sequence of SEQ ID NO:328.

3. A method for inducing an immune response in a subject against one or more strains of Dengue virus, comprising:

administering an isolated polypeptide of claim 1 to a subject, wherein the subject produces an immune response to Dengue virus.

4. A kit, comprising:

one or more isolated viral physicochemical properties (PCP)-consensus proteins having the sequence of SEQ ID NO:329, SEQ ID NO:326, SEQ ID NO:327, SEQ ID NO:328, or SEQ ID NO:333;

one or more isolated antibodies directed against the viral PCP-consensus proteins; or

a combination thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2012
From: SCHEIN, CATHERINE H.; DANECEK, PETR
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 028580/0490 →
Continuity (2)
Provisional Application 61281555 · Nov 18, 2009
Related Publication 20130071418A1 · Mar 21, 2013